Celldex Therapeutics, Inc.
Anti-ALK antibodies and methods for use thereof
Last updated:
Abstract:
Provided herein are compositions, methods and uses involving antibodies that specifically bind to ALK, a receptor tyrosine kinase, and modulate the expression and/or activity of ALK. Also provided are uses and methods for treating, e.g., managing, disorders, such as cancer.
Status:
Grant
Type:
Utility
Filling date:
26 Aug 2016
Issue date:
17 Aug 2021